comparemela.com

Bx Gsk Gb00bn7swp63 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GSK : Deutsche Bank keeps its Buy rating

Already positive, the research from Deutsche Bank and its analyst Emmanuel Papadakis still consider the stock as a Buy opportunity. The target price continues to be set at GBX 1700. | June 8, 2023

GSK : Barclays sticks Neutral | MarketScreener

Barclays confirms his opinion on the stock and remains Neutral. The target price is still set at GBX 1450. | June 5, 2023

GSK : JP Morgan remains a Sell rating

JP Morgan analyst James Gordon reiterate his Sell rating on the stock. The target price is still set at GBX 1400. | May 9, 2023

GSK : JP Morgan remains a Sell rating

In a research note published by James Gordon, JP Morgan advises its customers to Sell the stock. The target price continues to be set at GBX 1400. | May 4, 2023

GSK : Credit Suisse remains Neutral | MarketScreener

In his latest research note, analyst Dominic Lunn confirms his recommendation. The broker Credit Suisse is keeping its Neutral rating. The target price remains unchanged at GBX 1510. | April 27, 2023

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.